3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
32
Multiple Myeloma
23
Leukemia, Myeloid, Acute
23
Lymphoma
17
Colorectal Neoplasms
16
Breast Neoplasms
14
Pancreatic Neoplasms
12
Myelodysplastic Syndromes
12
Triple Negative Breast Neoplasms
10
Sarcoma
9
Prostatic Neoplasms
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Burkitt Lymphoma
9
Ovarian Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, T-Cell
7
Glioma
7
Endometrial Neoplasms
7
Neuroblastoma
6
Melanoma
6
Lymphoma, Non-Hodgkin
6
Lung Neoplasms
6
Carcinoma, Renal Cell
6
Urinary Bladder Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Myeloproliferative Disorders
5
Lymphoma, Follicular
5
Fallopian Tube Neoplasms
5
Cholangiocarcinoma
5
Central Nervous System Neoplasms
5
Interventions
lutetium Lu 177 dotatate
8
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
pembrolizumab
3
olaparib
2
fludarabine
2
cabozantinib
2
X-Rays
2
Phantoms, Imaging
2
Cyclophosphamide
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
repotrectinib
1
peposertib
1
pazopanib
1
lenvatinib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
aldesleukin
1
Yttrium-90
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
PT-100 dipeptide
1
Octreotide
1
Nivolumab
1
Introns
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Biopsy
×
30 days
×
Clear all
No trials found.